How gut bacteria influence aging and Alzheimer's disease

The role of microbiota in aging and Alzheimer's disease

NIH-funded research Brigham and Women's Hospital · NIH-10875763

This study is looking at how the bacteria in your gut might affect the progression of Alzheimer's disease, and it aims to find out if changing these gut bacteria could help improve the condition for people living with Alzheimer's.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10875763 on NIH RePORTER

What this research studies

This research investigates the connection between gut microbiota and Alzheimer's disease (AD), focusing on how specific gut bacteria may influence the disease's progression. The study aims to identify mechanisms by which gut microbes affect AD pathology, including their role in processing amyloid precursor protein (APP) and modulating immune responses. By analyzing the gut microbiome of individuals with AD, researchers will explore potential microbial treatments that could alter disease outcomes. Patients may be involved in providing samples or participating in interventions aimed at understanding these relationships.

Who could benefit from this research

Good fit: Ideal candidates for participation include individuals diagnosed with Alzheimer's disease or those at risk for developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that modify gut bacteria to slow or prevent the progression of Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the role of gut microbiota in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.